1.
AJR Am J Roentgenol
; 191(6): 1740-4, 2008 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19020245
RESUMEN
OBJECTIVE: The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. CONCLUSION: Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.